Alcohol consumption is one of the most well-established risk factors for colorectal cancer (CRC). Global estimates suggest that about one in ten colorectal cancers is attributable to alcohol consumption, making it one of the most significant modifiable risk factors for this disease. Despite this clear epidemiological link, the biological mechanisms through which alcohol promotes colorectal cancer are not fully understood.
Alcohol can damage DNA directly through its metabolic byproducts - primarily acetaldehyde, a toxic compound generated when the body breaks down ethanol via the alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) enzymes. Acetaldehyde can form chemical bonds with DNA, causing mutations. Alcohol also affects immune function, promotes inflammation, and alters hormone levels in ways that could contribute to cancer development.
Recently, attention has turned to the gut microbiome - the trillions of bacteria living in the colon - as a possible pathway through which alcohol promotes colorectal cancer. Some gut bacteria can metabolize residual alcohol into acetaldehyde locally in the colon, potentially causing DNA damage directly at the colonic lining. Others may shift the bacterial community balance in ways that promote inflammation and cancer development.
This study analyzed data from the CRCbiome study, a substudy of the Bowel Cancer Screening in Norway (BCSN) trial. BCSN was a large national screening program comparing once-only sigmoidoscopy versus repeated fecal immunochemical testing (FIT) in participants aged 55-77. People with positive FIT tests were referred for colonoscopy to identify colorectal lesions.
The CRCbiome study enriched this screening cohort with detailed gut microbiome profiling using shotgun metagenomics - a comprehensive DNA-sequencing approach that identifies all bacteria present in fecal samples and their functional capabilities, not just their identities. This provides a much richer picture of gut bacterial activity than traditional bacterial culture methods.
Participants also completed a validated food frequency questionnaire (FFQ) covering their typical diet over the past year, including detailed alcohol consumption by beverage type. This combination of rigorous dietary assessment, comprehensive microbiome profiling, and colonoscopy outcomes makes the CRCbiome dataset uniquely powerful for studying diet-microbiome-cancer relationships.
The analysis included 1,486 participants who had completed dietary questionnaires, with 947 of these also having gut metagenomic profiles from fecal samples. Alcohol intake was categorized into four groups: none, low (more than 0 to 10 g/day), moderate (10-20 g/day), and high (20 g or more per day) consumption.
Colonoscopy findings were classified as: advanced lesions (including colorectal cancer and advanced adenomas), non-advanced adenomas, or controls (no lesions). Advanced lesions represent the most clinically significant outcome, as these are the precursors and early forms of colorectal cancer that bowel cancer screening aims to detect and prevent.
Causal mediation analysis - a statistical technique specifically designed to test whether one factor (gut bacteria) lies on the causal path between another factor (alcohol) and an outcome (colorectal lesions) - was used to estimate what fraction of alcohol's cancer-promoting effect passes through the microbiome. This method goes beyond simple correlation to explore potential cause-and-effect relationships.
Among the 1,486 participants with dietary data, 414 were diagnosed with advanced colorectal lesions at colonoscopy. The analysis confirmed a statistically significant, dose-dependent relationship between alcohol intake and advanced lesions: for every additional 10 grams of alcohol consumed per day (roughly one standard alcoholic drink), the odds of having advanced lesions increased by 9% (odds ratio 1.09, 95% CI 1.00-1.19, p-trend = 0.008).
Compared to non-drinkers, people consuming any amount of alcohol showed a distinct gut microbial profile. Changes were observed in both alpha diversity (the variety of bacteria species within a person's gut) and beta diversity (differences in community composition between individuals). Alcohol drinkers had consistently different bacterial communities from non-drinkers.
Specific bacterial species were found to be more or less abundant in alcohol drinkers compared to non-drinkers. These differentially abundant bacteria represent candidates for the microbial mechanisms through which alcohol might affect colorectal cancer risk. Their identification is a key step toward understanding - and potentially targeting - the gut microbial pathway in cancer prevention.
The causal mediation analysis provided the study's most important finding: approximately 12% of the association between alcohol intake and advanced colorectal lesions was statistically mediated through alcohol-associated gut bacteria. This means that some - though not all - of alcohol's cancer-promoting effect in the colon appears to work through changes to the gut microbiome.
This 12% mediated fraction is scientifically significant because it establishes for the first time in a population-based screening cohort that gut bacteria are not merely bystanders but active participants in the alcohol-colorectal cancer relationship. It suggests that the microbiome is one biological pathway - among likely several - through which alcohol promotes colorectal carcinogenesis.
The remaining 88% of the alcohol-cancer association is not explained by these microbial changes and likely involves the direct carcinogenic mechanisms of acetaldehyde in the bloodstream, alcohol's effects on DNA repair, its promotion of oxidative stress, and its influence on systemic hormone and immune function. The microbiome pathway is thus one important piece of a complex biological puzzle.
Two main biological mechanisms could explain the microbial mediation of alcohol's cancer-promoting effects. First, certain gut bacteria can ferment residual alcohol in the colon to produce acetaldehyde locally - the same carcinogenic compound produced by liver metabolism. This local production exposes the colonic epithelium (the cells lining the colon) to acetaldehyde in higher concentrations than reach the colon through systemic circulation.
Second, alcohol consumption shifts the balance of the gut bacterial ecosystem toward acetate-consuming bacteria, altering the chemical environment of the colon in ways that may promote inflammation, compromise the integrity of the gut lining (leaky gut), and create conditions favorable to tumor development. Chronic low-grade inflammation driven by an altered microbiome is a well-recognized driver of colorectal cancer development.
The study also notes that alcohol-associated gut bacterial changes occur in a consistent, dose-dependent manner, mirroring the dose-dependent risk of colorectal lesions. This parallel supports the causal interpretation: it is not that heavy drinkers happen to also have unhealthy microbiomes for unrelated reasons, but that alcohol itself progressively reshapes the microbial environment in cancer-promoting ways.
The finding that the gut microbiome mediates part of alcohol's cancer risk suggests a potential new prevention strategy: targeting the gut microbiome. If specific bacteria are responsible for converting alcohol into carcinogenic acetaldehyde in the colon, then interventions that reduce these bacteria (through dietary changes, probiotics, or other means) might reduce colorectal cancer risk in people who drink alcohol.
At the population level, this research reinforces public health messages about reducing alcohol consumption as a key colorectal cancer prevention strategy. The dose-response relationship means there is no safe lower threshold - even light-to-moderate drinking incrementally increases risk. The finding that gut bacteria are involved means colorectal cancer risk could potentially be monitored through stool-based microbial biomarkers.
Future research should identify the specific bacterial species and metabolic pathways responsible for the mediated portion of risk, verify whether correcting these bacterial alterations reduces lesion development in intervention studies, and examine whether the alcohol-microbiome-cancer pathway differs by genetics, dietary patterns, or other lifestyle factors that shape the gut microbiome.